JP2001513814A - 小児科手術におけるレボブピバカインの使用 - Google Patents

小児科手術におけるレボブピバカインの使用

Info

Publication number
JP2001513814A
JP2001513814A JP53827698A JP53827698A JP2001513814A JP 2001513814 A JP2001513814 A JP 2001513814A JP 53827698 A JP53827698 A JP 53827698A JP 53827698 A JP53827698 A JP 53827698A JP 2001513814 A JP2001513814 A JP 2001513814A
Authority
JP
Japan
Prior art keywords
levobupivacaine
bupivacaine
hcl
dose
absence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53827698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513814A5 (cg-RX-API-DMAC10.html
Inventor
ジェナリー,ブライアン・アルバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of JP2001513814A publication Critical patent/JP2001513814A/ja
Publication of JP2001513814A5 publication Critical patent/JP2001513814A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP53827698A 1997-03-03 1998-03-03 小児科手術におけるレボブピバカインの使用 Pending JP2001513814A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9704351.7 1997-03-03
GBGB9704351.7A GB9704351D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
PCT/GB1998/000664 WO1998038999A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in paediatric surgery

Publications (2)

Publication Number Publication Date
JP2001513814A true JP2001513814A (ja) 2001-09-04
JP2001513814A5 JP2001513814A5 (cg-RX-API-DMAC10.html) 2005-08-11

Family

ID=10808602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53827698A Pending JP2001513814A (ja) 1997-03-03 1998-03-03 小児科手術におけるレボブピバカインの使用

Country Status (20)

Country Link
US (1) US5910502A (cg-RX-API-DMAC10.html)
EP (1) EP0981348B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001513814A (cg-RX-API-DMAC10.html)
KR (1) KR100535554B1 (cg-RX-API-DMAC10.html)
CN (1) CN1107504C (cg-RX-API-DMAC10.html)
AT (1) ATE240731T1 (cg-RX-API-DMAC10.html)
AU (1) AU719483B2 (cg-RX-API-DMAC10.html)
BR (1) BR9808302A (cg-RX-API-DMAC10.html)
CA (1) CA2279498C (cg-RX-API-DMAC10.html)
DE (1) DE69814852T2 (cg-RX-API-DMAC10.html)
DK (1) DK0981348T3 (cg-RX-API-DMAC10.html)
ES (1) ES2199424T3 (cg-RX-API-DMAC10.html)
GB (1) GB9704351D0 (cg-RX-API-DMAC10.html)
HU (1) HU224227B1 (cg-RX-API-DMAC10.html)
IL (1) IL131086A0 (cg-RX-API-DMAC10.html)
NO (1) NO324215B1 (cg-RX-API-DMAC10.html)
PL (1) PL190896B1 (cg-RX-API-DMAC10.html)
PT (1) PT981348E (cg-RX-API-DMAC10.html)
WO (1) WO1998038999A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA981780B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
ATE507816T1 (de) * 2001-11-14 2011-05-15 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
WO2004012703A1 (en) * 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
CN1684663A (zh) * 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
HK1022649A1 (en) 2000-08-18
HUP0000963A3 (en) 2000-10-30
ES2199424T3 (es) 2004-02-16
BR9808302A (pt) 2000-05-16
NO324215B1 (no) 2007-09-10
DK0981348T3 (da) 2003-09-15
HUP0000963A2 (hu) 2000-09-28
HU224227B1 (hu) 2005-06-28
NO994259L (no) 1999-11-02
DE69814852D1 (de) 2003-06-26
ATE240731T1 (de) 2003-06-15
ZA981780B (en) 1999-03-03
KR100535554B1 (ko) 2005-12-08
AU719483B2 (en) 2000-05-11
PT981348E (pt) 2003-09-30
CA2279498C (en) 2009-05-26
IL131086A0 (en) 2001-01-28
US5910502A (en) 1999-06-08
PL190896B1 (pl) 2006-02-28
CN1107504C (zh) 2003-05-07
EP0981348B1 (en) 2003-05-21
GB9704351D0 (en) 1997-04-23
PL335563A1 (en) 2000-05-08
CA2279498A1 (en) 1998-09-11
WO1998038999A1 (en) 1998-09-11
KR20000075894A (ko) 2000-12-26
DE69814852T2 (de) 2004-01-22
NO994259D0 (no) 1999-09-02
AU6631098A (en) 1998-09-22
EP0981348A1 (en) 2000-03-01
CN1249683A (zh) 2000-04-05

Similar Documents

Publication Publication Date Title
CA2279498C (en) The use of levobupivacaine in paediatric surgery
US5849763A (en) Use of levobupivacaine as an anesthetic agent
KR100343314B1 (ko) 만성통증치료에유용한레보부피바카인
JP2001510795A (ja) レボブピバカインとその使用
JP2001513812A (ja) 顔面手術におけるレボブピバカインの使用
Klamt et al. Analgesic and adverse effects of a low dose of intrathecally administered hyperbaric neostigmine alone or combined with morphine in patients submitted to spinal anaesthesia: pilot studies
Zohar et al. Patient-controlled bupivacaine wound instillation following cesarean section: the lack of efficacy of adjuvant ketamine
CN1128620C (zh) 左布比卡因在制备治疗偏头痛的药物中的用途
JP2001510794A (ja) レボブピバカインとその使用
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
CA2165446C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Hersh et al. Anesthetic activity of the lipospheres bupivacaine delivery system in the rat
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
JP2000515547A (ja) 双極性障害の治療方法
MXPA99008057A (en) The use of levobupivacaine in paediatric surgery
HK1022649B (en) The use of levobupivacaine in paediatric surgery
US5362731A (en) Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders
JP2003504396A (ja) マクロライド化合物の新規用途
Dube A Comparative, Randomized, Open Labelled Study of the Clinical Efficacy and Safety of Intrathecal Levobupivacaine and Bupivacaine in Lower Limb Surgeries at a Tertiary Care Centre
Lerman et al. Regional Analgesia Techniques
MXPA99008056A (en) The use of levobupivacaine or ropivacaine in treating migraine
JPH062674B2 (ja) 抗めまい剤
WO1998026778A1 (en) Remedies/preventives for abnormal motions accompanying disorders in extrapyramidal system

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080916

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090303